title: A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic.
abstract: The study examined the impact of using a quality of life (QoL) questionnaire during a clinic to identify QoL issues and to improve QoL. 138 patients were randomised (1:1:1) to either (1) an Intervention group that completed the European Organisation for Research and Treatment of Cancer-Core Quality of Life Questionnaire and Lung Cancer Module (EORTC QLQ-C30 and LC13) at baseline and received feedback during a clinic, (2) an Attention group that completed the questionnaire at baseline without feedback and (3) a Control group that did not complete the questionnaire. All patients completed the same questionnaire 6 weeks later and a contact diary during the study period. There was a significant difference between the Intervention and Control groups for the mean number of QoL issues identified at baseline (4.69 vs. 2.81, P = 0.006) and the mean number of actions taken (4.41 vs. 2.46, P = 0.004). At 6 weeks, there was no difference between the groups in global QoL (Intervention vs. Control group, P = 0.596; Attention vs. Control, P = 0.973). The results suggest that the completion of the EORTC QLQ-C30 LC13 with feedback improves communication and increases the number of QoL issues identified and actions taken. However, the intervention does not impact on QoL per se. Clinicaltrials.gov: NCT01213745.
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.|Surrey and Sussex Healthcare NHS Trust, Surrey, UK.
authors.forename: K
authors.initials: K
authors.lastname: Nimako
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.
authors.forename: B
authors.initials: B
authors.lastname: Ayite
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.
authors.forename: K
authors.initials: K
authors.lastname: Priest
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.
authors.forename: J
authors.initials: J
authors.lastname: Severn
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.
authors.forename: H M
authors.initials: HM
authors.lastname: Fries
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.
authors.forename: R
authors.initials: R
authors.lastname: Gunapala
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.
authors.forename: J
authors.initials: J
authors.lastname: Bhosle
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.|Molecular Genetics and Genomics Group, Imperial College London, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Popat
authors.affiliation: The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK.
authors.forename: M
authors.initials: M
authors.lastname: O'Brien
mesh_terms: D000203:Activities of Daily Living; D000704:Analysis of Variance; D002173:Cancer Care Facilities; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D008654:Mesothelioma / Q000628:therapy*; D008875:Middle Aged; D011788:Quality of Life; D011795:Surveys and Questionnaires / Q000592:standards*; D016896:Treatment Outcome
keywords: lung cancer; quality of life; supportive care; symptoms